Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296613612> ?p ?o ?g. }
- W4296613612 endingPage "1990" @default.
- W4296613612 startingPage "1990" @default.
- W4296613612 abstract "Cancer immunotherapy has shown impressive anti-tumor activity in patients with advanced and early-stage malignant tumors, thus improving long-term survival. However, current cancer immunotherapy is limited by barriers such as low tumor specificity, poor response rate, and systemic toxicities, which result in the development of primary, adaptive, or acquired resistance. Immunotherapy resistance has complex mechanisms that depend on the interaction between tumor cells and the tumor microenvironment (TME). Therefore, targeting TME has recently received attention as a feasibility strategy for re-sensitizing resistant neoplastic niches to existing cancer immunotherapy. With the development of nanotechnology, nanoplatforms possess outstanding features, including high loading capacity, tunable porosity, and specific targeting to the desired locus. Therefore, nanoplatforms can significantly improve the effectiveness of immunotherapy while reducing its toxic and side effects on non-target cells that receive intense attention in cancer immunotherapy. This review explores the mechanisms of tumor microenvironment reprogramming in immunotherapy resistance, including TAMs, CAFs, vasculature, and hypoxia. We also examined whether the application of nano-drugs combined with current regimens is improving immunotherapy clinical outcomes in solid tumors." @default.
- W4296613612 created "2022-09-23" @default.
- W4296613612 creator A5028296024 @default.
- W4296613612 creator A5029879333 @default.
- W4296613612 creator A5042084374 @default.
- W4296613612 creator A5078667387 @default.
- W4296613612 creator A5090740656 @default.
- W4296613612 creator A5091448543 @default.
- W4296613612 date "2022-09-21" @default.
- W4296613612 modified "2023-10-01" @default.
- W4296613612 title "Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications" @default.
- W4296613612 cites W1039337982 @default.
- W4296613612 cites W1157613785 @default.
- W4296613612 cites W1440506460 @default.
- W4296613612 cites W1501133927 @default.
- W4296613612 cites W1571418278 @default.
- W4296613612 cites W1573363574 @default.
- W4296613612 cites W1596848781 @default.
- W4296613612 cites W1810166418 @default.
- W4296613612 cites W1871308790 @default.
- W4296613612 cites W1898110144 @default.
- W4296613612 cites W1914241837 @default.
- W4296613612 cites W1967229707 @default.
- W4296613612 cites W1983575915 @default.
- W4296613612 cites W1983979770 @default.
- W4296613612 cites W1988307856 @default.
- W4296613612 cites W1991031388 @default.
- W4296613612 cites W1991782658 @default.
- W4296613612 cites W1991799167 @default.
- W4296613612 cites W1997138202 @default.
- W4296613612 cites W2000285060 @default.
- W4296613612 cites W2002906517 @default.
- W4296613612 cites W2004150448 @default.
- W4296613612 cites W2011219093 @default.
- W4296613612 cites W2012328307 @default.
- W4296613612 cites W2014282546 @default.
- W4296613612 cites W2015554909 @default.
- W4296613612 cites W2016829755 @default.
- W4296613612 cites W2018226517 @default.
- W4296613612 cites W2023879569 @default.
- W4296613612 cites W2025036947 @default.
- W4296613612 cites W2026038729 @default.
- W4296613612 cites W2028156849 @default.
- W4296613612 cites W2028619856 @default.
- W4296613612 cites W2032647804 @default.
- W4296613612 cites W2040577378 @default.
- W4296613612 cites W2042138520 @default.
- W4296613612 cites W2045449124 @default.
- W4296613612 cites W2046972425 @default.
- W4296613612 cites W2053077212 @default.
- W4296613612 cites W2054063883 @default.
- W4296613612 cites W2055624262 @default.
- W4296613612 cites W2058648826 @default.
- W4296613612 cites W2060420887 @default.
- W4296613612 cites W2062554435 @default.
- W4296613612 cites W2069722998 @default.
- W4296613612 cites W2070143261 @default.
- W4296613612 cites W2072497851 @default.
- W4296613612 cites W2076471215 @default.
- W4296613612 cites W2082503761 @default.
- W4296613612 cites W2085138770 @default.
- W4296613612 cites W2087690546 @default.
- W4296613612 cites W2088571368 @default.
- W4296613612 cites W2089333071 @default.
- W4296613612 cites W2092738402 @default.
- W4296613612 cites W2102448742 @default.
- W4296613612 cites W2104888958 @default.
- W4296613612 cites W2108122457 @default.
- W4296613612 cites W2109424201 @default.
- W4296613612 cites W2110088592 @default.
- W4296613612 cites W2116263694 @default.
- W4296613612 cites W2117692326 @default.
- W4296613612 cites W2120426523 @default.
- W4296613612 cites W2140570135 @default.
- W4296613612 cites W2142644858 @default.
- W4296613612 cites W2145453174 @default.
- W4296613612 cites W2156545114 @default.
- W4296613612 cites W2165836181 @default.
- W4296613612 cites W2166315000 @default.
- W4296613612 cites W2169133530 @default.
- W4296613612 cites W2171902233 @default.
- W4296613612 cites W2230939498 @default.
- W4296613612 cites W2254024193 @default.
- W4296613612 cites W2260067559 @default.
- W4296613612 cites W2267659431 @default.
- W4296613612 cites W2268788143 @default.
- W4296613612 cites W2286320137 @default.
- W4296613612 cites W2309652257 @default.
- W4296613612 cites W2322088639 @default.
- W4296613612 cites W2326188833 @default.
- W4296613612 cites W2328555801 @default.
- W4296613612 cites W2406755887 @default.
- W4296613612 cites W2408039933 @default.
- W4296613612 cites W2413193118 @default.
- W4296613612 cites W2427645657 @default.
- W4296613612 cites W2436942341 @default.
- W4296613612 cites W2468690265 @default.
- W4296613612 cites W2489212590 @default.